The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dioralyte Rebalance Blackcurrant Powder for Oral Solution

Opella Healthcare France SAS T/A SanofiPA23180/023/001

Main Information

Trade NameDioralyte Rebalance Blackcurrant Powder for Oral Solution
Active SubstancesSodium chloride
Potassium chloride
Disodium hydrogen citrate
Dosage FormPowder for oral solution
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/023/001

Group Information

ATC CodeA07CA Oral rehydration salt formulations


License statusAuthorised
Licence Issued14/02/2020
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back